SCHEMBL3887599

SCHEMBL3887599

CC1CC2(CCN1C(=O)O)C(NC(=O)OC(C)(C)C)=NC(=O)N2c1cccc(F)c1

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 2/20 0.34
BACE1 P56817 1/20 0.33
BACE2 Q9Y5Z0 1/20 0.33
GRM5 P41594 1/20 0.33
GRM1 Q13255 1/20 0.33
KCNJ6 P48051 2/20 0.33
KCNJ3 P48549 2/20 0.33
TP53 P04637 2/20 0.32
CDK9 P50750 1/20 0.32
RORC P51449 3/20 0.32
KCNJ5 P48544 1/20 0.31
JAK2 O60674 2/20 0.31
JAK1 P23458 2/20 0.31
CPB2 Q96IY4 1/20 0.31
EEF2K O00418 1/20 0.31
CNR2 P34972 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3492314 1.00 HPGDS (0.34) HPGDSBACE1BACE2GRM5GRM1
SCHEMBL13435140 0.89 PDK1 (0.38) BACE1TP53CDK9RORCJAK2
SCHEMBL4249026 0.86 KCNJ6 (0.35) BACE1BACE2KCNJ6KCNJ3KCNJ5
SCHEMBL3479619 0.86 KCNJ6 (0.35) BACE1BACE2KCNJ6KCNJ3KCNJ5
SCHEMBL13435142 0.84 OPRM1 (0.37) HPGDSBACE1BACE2EEF2K
SCHEMBL13435141 0.84 HPGDS (0.35) HPGDSBACE1BACE2GRM5GRM1
SCHEMBL5326122 0.82 ADORA3 (0.39) BACE1BACE2
SCHEMBL3479516 0.81 MAPK14 (0.39) BACE1BACE2KCNJ6KCNJ3KCNJ5
SCHEMBL3893080 0.81 MAPK14 (0.39) BACE1BACE2KCNJ6KCNJ3KCNJ5
SCHEMBL5616430 0.80 BACE1 (0.35) BACE1BACE2KCNJ6KCNJ3KCNJ5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2091328-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck & Co., Inc. (US) 2009-08-26 EP disclosed
WO-2008054698-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2008-05-08 WO disclosed